Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2019Reviews in Medical Virology

Progressive multifocal leukoencephalopathy and anti‐CD20 monoclonal antibodies: What do we know after 20 years of rituximab

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDaniele FocosiBank of ItalyMTMarco TuccoriUniversity of VeronaFMFabrizio MaggiUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Focosi et al. (2019) studied this question.

synapsesocial.com/papers/69dbd630c9a120f055a3cb31https://doi.org/10.1002/rmv.2077
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient2013 · 20 citations
  2. 2Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 72014 · 98 citations